Smart technology for patient-centered care in pulmonary embolism
Official title: Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism:A Multicenter, Randomized Controlled Trial
Run by Navy General Hospital, Beijing · NCT06382038 · Data updated 2026-11-12
A smartphone-based program using wearable tech and AI will help people with pulmonary embolism manage their health and see if it improves long-term outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2972 (estimated) |
| Sponsor | Navy General Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | August 20, 2026 |
| Main results expected | September 30, 2028 |
| Study ends | September 30, 2029 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT06382038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with imaging-confirmed pulmonary embolism, either newly diagnosed during the current hospitalization or with residual thrombus from a prior event, who can use smartphones or tablets and consent to participate.
✕Probably not a fit
Patients unable to use smart devices or with conditions preventing independent living may not benefit from this digital intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial tests a mobile health application designed for patients with pulmonary embolism, incorporating wearable and digital tools to support pre-warning, decision support, education, and ongoing care. It focuses on long-term outcomes and aims to inform best practices for managing PTE through technology-assisted, patient-centered care. Participants are adults with imaging-confirmed PTE who can use smart devices, and the intervention is delivered through the mVTEA app. The study is sponsor-led by Navy General Hospital in Beijing, with enrollment at a single center in Beijing. Results could help determine whether digital health approaches can enhance access to high-quality resources and improve thrombosis management.
Why it matters
Potential benefit: If successful, patients may experience better long-term management and outcomes through continuous monitoring and education enabled by mobile technology.
How similar studies have gone: Digital health tools have shown mixed results in thrombosis care, with some studies indicating potential benefits in management and education, while broader, definitive evidence remains evolving.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inpatients aged ≥18 years; * PTE confirmed through imaging examinations, meeting at least one of the following criteria: a.Newly diagnosed PTE during the current hospitalization; b. Prior PTE with imaging evidence of residual thrombus. * Signed informed consent. Exclusion Criteria: * Previous PTE combined with CTEPH; * Mental retardation or a combination of other serious illnesses that make them incapable of living on their own; * Inability to use smartphones, computer tablets and other smart devices; * Being pregnant or breastfeeding; * Have participated in similar trials or are undergoing other clinical trials.
Where it's running
-
Sixth Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: ZHI-GENG JIN, Doctor
- Email: lwgjzg@163.com
- Phone: 8615801402223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted whole-course management for safe medicine use in advanced solid tumors
A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.
-
DoACs vs LMWH for blood flow after knee replacement
This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.
-
Digitally Enabled Districts 2.0: Aimed at Improving Maternal and Neonatal Care in Garut
A stepped-wedge trial tests whether an integrated digital health ecosystem helps 45 local clinics in Garut improve the completeness and timeliness of maternal and neonatal care.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit
This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.